Search

Your search keyword '"Fisher"' showing total 2,587 results

Search Constraints

Start Over You searched for: Author "Fisher" Remove constraint Author: "Fisher" Journal blood Remove constraint Journal: blood
2,587 results on '"Fisher"'

Search Results

3. A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

6. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

11. Influence of Household Income on Health-Related Quality of Life in Children with Acute Myeloid Leukemia

12. A Phase 2 Study of Pembrolizumab (MK-3475) after Autologous Stem Cell Transplantation in Patients with T-Cell Non-Hodgkin Lymphoma

14. Dual Immune Checkpoint Agents in Combination with Rituximab for Patients with Relapsed or Refractory Follicular Lymphoma

16. Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

17. Candidate driver genes involved in genome maintenance and DNA repair in Sézary syndrome

18. Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies

21. EP0042, a Dual FLT3 and Aurora Kinase Inhibitor: Preliminary Results of an Ongoing Phase I/IIa First in Human Study in Patients with Relapsed/Refractory Acute Myeloid Leukemia

23. Septic Shock and Septic Shock Mortality in Relation to Social Disorganization Index Among Children Being Treated for De Novo Acute Myeloid Leukemia on COG Clinical Trials

24. Transcriptional and Metabolic Profiling Reveals Alpha-Ketoglutarate As a Novel Mediator of Aberrant Platelet Activity and Inflammation in Myeloproliferative Neoplasms

25. Dual Immune Checkpoint Agents in Combination with Rituximab for Patients with Relapsed or Refractory Follicular Lymphoma

26. Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)

28. CFT7455, a Novel IKZF1/3 Degrader, Demonstrates Potent Anti-Tumor Activity in Models of Non-Hodgkin's Lymphoma As a Single Agent or in Combination with Clinically Approved Agents

29. Older Adults with Acute Myeloid Leukemia (AML) Treated in a Pragmatic Trial: How Do Patients’ Function and Health-Related Quality of Life Change with Treatment?

30. Chronic Graft Versus Host Disease Detected By Tissue-Specific Cell-Free DNA Methylation Biomarkers

31. A Phase 2 Study of Pembrolizumab (MK-3475) after Autologous Stem Cell Transplantation in Patients with T-Cell Non-Hodgkin Lymphoma

32. Updated Results from a Multicenter, Phase 2 Study of Acalabrutinib, Venetoclax, Obinutuzumab (AVO) in a Population of Previously Untreated Patients with CLL Enriched for High-Risk Disease

33. Influence of Household Income on Health-Related Quality of Life in Children with Acute Myeloid Leukemia

34. Development of a Pediatric AML Patient Derived Xenograft Program

35. Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race

37. High Incidence and Mortality of Invasive Fungal Disease in Children and Young Adults with Hematologic Malignancies in Hawaii and Pacific Islands

38. Regulation of iron homeostasis by hepatocyte TFR1 requires HFE and contributes to hepcidin suppression in β-thalassemia

39. Mutations in Krüppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression

42. Development of a Pediatric AML Patient Derived Xenograft Program

45. Updated Results from a Multicenter, Phase 2 Study of Acalabrutinib, Venetoclax, Obinutuzumab (AVO) in a Population of Previously Untreated Patients with CLL Enriched for High-Risk Disease

50. A remarkable case of HbH disease illustrates the relative contributions of the α-globin enhancers to gene expression

Catalog

Books, media, physical & digital resources